Published in J Cereb Blood Flow Metab on January 01, 2004
NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration. Nature (2008) 2.01
The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci (2005) 1.84
Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci (2014) 1.66
Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress. J Neurosci (2008) 1.54
Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene. Mol Cell Proteomics (2007) 1.35
Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease. Hum Mol Genet (2009) 1.26
NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia. J Cereb Blood Flow Metab (2010) 1.17
CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy. Hum Mol Genet (2011) 1.12
Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds). Genome Biol (2008) 1.02
Serum or target deprivation-induced neuronal death causes oxidative neuronal accumulation of Zn2+ and loss of NAD+. Eur J Neurosci (2010) 0.96
Concepts for regulation of axon integrity by enwrapping glia. Front Cell Neurosci (2013) 0.91
Consistent injury to medium spiny neurons and white matter in the mouse striatum after prolonged transient global cerebral ischemia. J Neurotrauma (2011) 0.90
The neuroprotective factor Wld(s) fails to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of spinal muscular atrophy. Neurosci Lett (2008) 0.89
WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity. Mol Neurodegener (2012) 0.89
Design of a novel quantitative PCR (QPCR)-based protocol for genotyping mice carrying the neuroprotective Wallerian degeneration slow (Wlds) gene. Mol Neurodegener (2007) 0.88
Sodium and potassium currents influence Wallerian degeneration of injured Drosophila axons. J Neurosci (2013) 0.88
Retinal ganglion cell survival and axon regeneration in WldS transgenic rats after optic nerve crush and lens injury. BMC Neurosci (2012) 0.87
Synaptic protection in the brain of WldS mice occurs independently of age but is sensitive to gene-dose. PLoS One (2010) 0.87
Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1. Invest Ophthalmol Vis Sci (2013) 0.86
Light-induced photoreceptor and RPE degeneration involve zinc toxicity and are attenuated by pyruvate, nicotinamide, or cyclic light. Mol Vis (2010) 0.83
Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice. Prostaglandins Other Lipid Mediat (2012) 0.82
Delayed axonal degeneration in slow Wallerian degeneration mutant mice detected using diffusion tensor imaging. Neuroscience (2011) 0.82
Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection. Neurobiol Dis (2013) 0.81
Expression of the neuroprotective slow Wallerian degeneration (WldS) gene in non-neuronal tissues. BMC Neurosci (2009) 0.78
Death of an axon: studying axon loss in development and disease. Histochem Cell Biol (2005) 0.76
Activity-dependent degeneration of axotomized neuromuscular synapses in Wld S mice. Neuroscience (2015) 0.76
Molecular neuropathology of the synapse in sheep with CLN5 Batten disease. Brain Behav (2015) 0.76
Short-term diabetic hyperglycemia suppresses celiac ganglia neurotransmission, thereby impairing sympathetically mediated glucagon responses. Am J Physiol Endocrinol Metab (2015) 0.75
Importance of normothermia control in investigating delayed neuronal injury in a mouse global ischemia model. J Neurosci Methods (2009) 0.75
Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci (2008) 4.04
The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults. Neuron (2012) 1.97
The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci (2005) 1.84
Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature (2004) 1.71
Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol (2009) 1.53
The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain (2005) 1.46
Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo. J Neurosci (2009) 1.46
A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses. Eur J Neurosci (2005) 1.39
Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice. J Neurosci Methods (2004) 1.32
Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc Natl Acad Sci U S A (2010) 1.22
Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo. J Neurosci (2010) 1.22
Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion. Brain (2006) 1.20
The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. Hum Mol Genet (2006) 1.14
Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion. J Neurosci (2011) 1.13
The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus. Mol Biol Cell (2005) 1.13
Age-dependent synapse withdrawal at axotomised neuromuscular junctions in Wld(s) mutant and Ube4b/Nmnat transgenic mice. J Physiol (2002) 1.10
Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging (2010) 1.08
Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur J Neurosci (2007) 1.07
Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57Bl/6J mice. Brain Res (2004) 1.04
MRI is a sensitive marker of subtle white matter pathology in hypoperfused mice. Neurobiol Aging (2010) 1.02
Mutant alpha-latrotoxin (LTXN4C) does not form pores and causes secretion by receptor stimulation: this action does not require neurexins. J Biol Chem (2003) 1.02
Late onset distal axonal swelling in YFP-H transgenic mice. Neurobiol Aging (2007) 1.01
The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from WldS and other mutant mice. J Neurocytol (2004) 0.99
Activation of Nrf2-regulated glutathione pathway genes by ischemic preconditioning. Oxid Med Cell Longev (2011) 0.99
Progressive loss of motor neuron function in wasted mice: effects of a spontaneous null mutation in the gene for the eEF1 A2 translation factor. J Neuropathol Exp Neurol (2005) 0.97
Mild fluid percussion injury in mice produces evolving selective axonal pathology and cognitive deficits relevant to human brain injury. J Neurotrauma (2010) 0.96
ApoE isoform-specific regulation of regeneration in the peripheral nervous system. Hum Mol Genet (2011) 0.93
Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice. Neurobiol Dis (2004) 0.92
Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. J Cell Sci (2008) 0.89
Remodeling of motor nerve terminals in demyelinating axons of periaxin-null mice. Glia (2008) 0.89
Proteomic analysis of mitochondria in APOE transgenic mice and in response to an ischemic challenge. J Cereb Blood Flow Metab (2011) 0.88
Design of a novel quantitative PCR (QPCR)-based protocol for genotyping mice carrying the neuroprotective Wallerian degeneration slow (Wlds) gene. Mol Neurodegener (2007) 0.88
Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy. Mol Cell Neurosci (2009) 0.88
Neural stem cell grafts reduce the extent of neuronal damage in a mouse model of global ischaemia. Brain Res (2005) 0.86
Ultrastructural correlates of synapse withdrawal at axotomized neuromuscular junctions in mutant and transgenic mice expressing the Wld gene. J Anat (2003) 0.85
Axotomy-dependent and -independent synapse elimination in organ cultures of Wld(s) mutant mouse skeletal muscle. J Neurosci Res (2004) 0.84
Effect of limb lengthening on internodal length and conduction velocity of peripheral nerve. J Neurosci (2013) 0.83
VCP binding influences intracellular distribution of the slow Wallerian degeneration protein, Wld(S). Mol Cell Neurosci (2008) 0.83
APOE epsilon3 gene transfer attenuates brain damage after experimental stroke. J Cereb Blood Flow Metab (2006) 0.82
Regionally selective and dose-dependent effects of the ampakines Org 26576 and Org 24448 on local cerebral glucose utilisation in the mouse as assessed by 14C-2-deoxyglucose autoradiography. Neuropharmacology (2005) 0.79
Myo-GDNF increases non-functional polyinnervation of reinnervated mouse muscle. Neuroreport (2004) 0.78
Prevalence and elimination of sibling neurite convergence in motor units supplying neonatal and adult mouse skeletal muscle. J Comp Neurol (2012) 0.77
Segmentation of the mouse fourth deep lumbrical muscle connectome reveals concentric organisation of motor units. J Physiol (2013) 0.77
Upregulation of PKD1L2 provokes a complex neuromuscular disease in the mouse. Hum Mol Genet (2009) 0.76
Endocytic pathway alterations in human hippocampus after global ischemia and the influence of APOE genotype. Am J Pathol (2003) 0.75
Correction to 'NMJ-morph reveals principal components of synaptic morphology influencing structure-function relationships at the neuromuscular junction'. Open Biol (2017) 0.75